{"id":1480,"date":"2019-06-04T23:18:02","date_gmt":"2019-06-04T23:18:02","guid":{"rendered":"https:\/\/www.medicalmarijuanainc.com\/?p=425876"},"modified":"2019-06-04T23:18:02","modified_gmt":"2019-06-04T23:18:02","slug":"medical-marijuana-inc-ceo-shares-expertise-at-fdas-special-hearing-on-cbd","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2019\/06\/04\/medical-marijuana-inc-ceo-shares-expertise-at-fdas-special-hearing-on-cbd\/","title":{"rendered":"Medical Marijuana, Inc. CEO Shares Expertise at FDA\u2019s Special Hearing on CBD"},"content":{"rendered":"

Dr. Stuart Titus stood up before the FDA last week to share his perspective on how products containing cannabis and CBD should be regulated.<\/i><\/b><\/h4>\n

Medical Marijuana, Inc. CEO Dr. Stuart Titus addressed the U.S. Food and Drug Administration (FDA) on Friday, May 31, during the agency’s special public hearing to gather opinions on the regulation of cannabidiol (CBD).<\/p>\n